January 15, 2015 Issue of Biocentury Innovations

Total Page:16

File Type:pdf, Size:1020Kb

January 15, 2015 Issue of Biocentury Innovations JANUARY 15, 2015 COVER STORY TOOLS & TECHNIQUES 1 THE RIGHT CULTURE Stakeholders agree that mandating new methods to authenticate cell lines can improve reproducibility in THE RIGHT CULTURE research, but they don’t agree on who should lead the charge. By Michael J. Haas, Associate Editor Using the right cell line might sound like a topic for Lab Work 101, but PRODUCT R&D it is an issue at the heart of the reproducibility problem in preclinical research. A panel that met to discuss strategies for tackling the problem 6 EPIZYME’S MANTLE PIECE agreed that some emerging technologies for authenticating cell lines Epizyme adds PRMT5 to the list of epigenetic targets could make a difference, but found little common ground on which and believes it has a first-in-class inhibitor of the entities — journals, funding agencies or the private sector — should enzyme. be responsible for mandating their use. The panel was convened by the Global Biological Standards Institute TOOLS & TECHNIQUES in November as part of its inaugural BioPolicy Summit and focused on 9 BOOSTING IgG WITH IgA cell line authentication — a key factor identified in the institute’s 2013 A UT Austin team has engineered chimeric mAbs white paper on the need for standards in many areas of preclinical that induce more potent leukocyte-mediated killing of research. targeted cells than conventional IgGs. GBSI President Len Freedman told BioCentury that although several issues were outlined in that analysis, the institute chose to start with FINANCE this topic “because it is a clearly identifiable problem with known effects on results in research.” 12 CONSORTIA CROSS-TALK To include a cross-section of stakeholders in the discussion, GBSI drew Consortia are wising up to the need to avoid the four panelists from Roche’s Genentech Inc. unit, NIH’s National duplication of efforts and starting to coordinate their activities, but still need to bring more academics into Institute of General Medical Sciences (NIGMS), the Prostate Cancer the fold. Foundation (PCF) and Nature Publishing Group (NPG). Multiple studies have reported that up to one third of all cell lines used TRANSLATION IN BRIEF in preclinical research are misidentified — a problem that stems from lack of best handling practices and results in cross-contamination of 18 TRUTH IN A CELL cell lines. Cell line misidentification actually involves multiple issues, A single cell partnership for Fluidigm, Wellcome and including whether a cell line was correctly identified before use, EBI; allergy center in Stanford; Takeda joins Monash whether that line becomes contaminated or otherwise altered during for GI discovery experimentation, and whether multiple daughter cell lines generated from one cell line retain identity with one another and with their DISTILLERY parent line. 21 THE WEEK IN THERAPEUTICS However, the panelists said despite growing awareness of the issue, many researchers still don’t validate their cell lines. BNIP3 inhibitors for doxorubicin-induced cardiotoxicity; malaria vaccine from an engineered “Cell lines that were tagged as misidentified back in the 1960s are still parasite; NRTIs to treat dry AMD; and more... used” under their wrong identity by some researchers, said panelist Véronique Kiermer, executive editor and director of author and 27 THE WEEK IN TECHNIQUES reviewer services at NPG. “The consequences of using misidentified Cell-free detection of CTCs in blood; rare mutations cells can be very different depending on the study being done.” for predicting MI risk; 3D printing of meniscus tissue; and more... PRODUCT R&D TOOLS & TECHNIQUES FINANCE TRANSLATION IN BRIEF DISTILLERY “We need to set new standards to increase the integrity of the science we do from now on.” Richard Neve, Genentech Inc. Panelist Richard Neve, director of discovery oncology at Neve told BioCentury that to use the technique “at the level you Genentech, noted that although the implications for science should” was too time-consuming and costly even for Genentech. already done would never be fully known, the emphasis now “This is why we went with SNP-based profiling over STR, which should be forward looking. “We need to set new standards to could cost us tens of thousands of dollars annually.” increase the integrity of the science we do from now on,” he told In 2008, Genentech launched an in-house facility that banks the panel. all cell lines coming into the company and authenticates them Jon Lorsch, director of NIGMS, said his institute recognizes the before and after use by company researchers with a method — problem as a serious one and is implementing its own strategy also developed in-house — that utilizes 48 SNPs. “The initial for addressing it at the source of funding. “We’re formulating cost of reagents is about $6 per sample for the SNP-based new guidelines and procedures and asking grant applicants to method and $15-$30 per sample for STR, depending on which have a statement about authenticating cell lines,” he said. kit you use,” Neve told Biocentury. “The SNP profiling also cuts Howard Soule, CSO of PCF, indicated the not-for-profit sector the run-time by a factor of 4 or 5 over STR analysis.” is taking action as well. “We take this issue very seriously as a “We’ve not looked at whether we see more reproducibility, but responsibility to our donors,” he said. His organization is also we do catch mistakes earlier,” Neve told the panel. “We can have tying it to funding, and about a year ago began requiring its more confidence moving forward that the data being produced researchers to show cell line authentication results within one will be reproducible.” year of receiving grant money. Lorsch called Genentech’s approach “a step in the right direction,” but was not convinced it would provide a comprehensive STR-AIGHT TALK solution because not every researcher has the resources or All four panelists pointed to short tandem repeat (STR) motivation to set up an SNP-based authentication facility. analysis as the best available — if not the optimum — tool for authenticating cell lines. The approach involves profiling “We want to make it more feasible for researchers to do cell line hypervariable regions in DNA that are unique to an individual authentications in terms of the time, money and number of cell genome, which provides a distinct genetic fingerprint for any lines tested” — making it as easy as using a pH meter in a lab — human cell line. and NIH is considering how to encourage development of new technologies in this area, he told the panel. Many CROs and service companies now offer STR analysis to customers for about $150 per cell line with a turnaround time Lorsch also told BioCentury that new technologies are needed of about a week. But according to Kiermer, data collected by because STR lacks the genomic resolution needed to authenticate NPG from manuscript submissions show that only about 10% gene-edited cell lines. “For instance, it can’t tell you whether of researchers use STR analysis. She thinks that as its costs your HeLa cell line is the same as mine. So it would be useful to continue to decrease, the technique will become routine. have a rapid, cost-effective technique that could do this.” In the meantime, Lorsch told BioCentury, the cost of STR Keith Yamamoto, keynote speaker at the GBSI summit, agreed analysis presents researchers with a significant barrier to that STR analysis is limited in its ability to identify cell lines, compliance. “For example, if you have eight or nine people on especially in light of gene-editing techniques that are becoming your team working with a dozen cell lines and you’re doing STR more common. “In my view it would be more useful to have a on all of them every few months, this adds up,” he said. broader discussion on whether STR is really useful and how to develop new assays to identify cell lines,” he told BioCentury. 2 JanuarY 15, 2015 TOC PRODUCT R&D TOOLS & TECHNIQUES FINANCE TRANSLATION IN BRIEF DISTILLERY TOOLS & TECHNIQUES “I think cell lines will eventually have to be bar-coded.” Yamamoto is vice chancellor for research at JOURNALS TAKE ON REPRODUCIBILITY the University of California, San Francisco, and executive vice dean at the UCSF School While any one journal cannot single-handedly mandate best practices to the of Medicine. entire research community, together they can promote consensus standards to improve the reproducibility of published studies. Late last year, NIH released a POLICE QUESTION set of proposed principles and guidelines for reporting preclinical data that it put There was less harmony among panelists together after discussions with leaders of more than 100 life sciences journals. on who should shoulder the responsibility The guidelines were the result of about two years of work, according to Véronique for mandating standards or policing Kiermer, executive editor and director of author and reviewer services at Nature compliance. Publishing Group. As concern over irreproducibility in preclinical research rose in 2012, several NIH institutes — including the National Cancer Institute and the Kiermer’s position was that journals can National Institute of Neurological Disorders and Stroke — convened meetings impose standards for publication that might for scientists and journal editors to discuss the problem in the second half of that provide an incentive for better behaviors, but year, she told BioCentury. journals cannot be responsible for ensuring that researchers act as they should. That Following those meetings, some journals began instituting measures to encourage researchers to adhere to best practices while others augmented their requires other stakeholders, she said. existing measures or hung back waiting for further developments, said Kiermer. “It’s a community issue about good lab NPG, for example, created an 18-point checklist for submitters that requests management and best practices — like details about the study, including methods of statistical analysis, the source of asking a cook to use the freshest ingredients,” cell lines used, and whether the cell lines and reagents used had been validated.
Recommended publications
  • Final Program
    June 25-28, chicago, illinois Spotlight on Translational Immunology Scientific Program Create Your Masterpiece Alexa Fluor® 594 anti-Ki-67 Direct Antibody Conjugates for Multicolor Microscopy For multicolor uorescence microscopy, bright uorescence with little background is critical for speci c detection of antigens. Furthermore, directly labeled antibodies are essential for multicolor microscopy. BioLegend now introduces our line of antibodies directly conjugated to Alexa Fluor® 594, a bright, stable uorophore emitting into the red range of the color spectrum, ideal for imaging applications. Brilliant Violet 421™ is an exceptionally bright and photostable uorescent polymer well- suited for microscopy applications. BioLegend has over 100 IHC HeLa cells were xed, permeabilized, and blocked, then intracellularly stained with Ki-67 (clone Ki-67) Alexa Fluor® 594 (red) and Alexa Fluor® 488 or IF suitable clones conjugated to Brilliant Violet™, Alexa Fluor®, Phalloidin (green). Nuclei were counterstained with DAPI (blue). The image and DyLight®, including secondary antibodies and streptavidin. was captured with 40x objective. Learn more: biolegend.com/AF594 Alexa Fluor® is a trademark of Life Technologies Corporation. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd. biolegend.com/brilliantviolet DyLight® is a trademark of Thermo Fisher Scienti c Inc. and its subsidiaries. BioLegend is ISO 9001:2008 and ISO 13485:2003 Certi ed Toll-Free Tel: (US & Canada): 1.877.BIOLEGEND (246.5343) Tel: 858.768.5800 biolegend.com 08-0040-03 2 World-Class Quality | Superior Customer Support | Outstanding Value 08-0040-03.indd 1 5/13/14 8:54 AM Spotlight on Translational Immunology Dear Colleagues, Welcome to the 14th annual meeting of the Federation of Clinical Immunology Societies, FOCIS 2014.
    [Show full text]
  • STANFORD UNIVERSITY Research Consent Form Protocol Title
    IRB Use Only STANFORD UNIVERSITY Research Consent Form Approval Date: June 12, 2019 Expiration Date: June 12, 2020 Protocol Director: Kari Nadeau, MD PhD Protocol Title: T Cell Reagent Research for Monitoring T Cells in Food Allergy Phase 2 study using food Allergen Oral Immunotherapy for Shrimp or Cashew allergies Please check all that are applicable: I am an adult participant in this study. Print your name here: ______________________________________________________ I am the parent or guardian granting permission for a child in this study (the use of "you" refers to "your child" or “your ward.”) Print child’s name here: ______________________________________________________ ************* Are you participating in any other research studies? _____ Yes _____No You have been invited to take part in a clinical research study for people who are allergic to shrimp or cashew food. Your decision to take part in this study is voluntary. Concise Summary Goals of the Study 1) To learn how the shrimp and cashew food allergen affects people’s immune system 2) If analyzing immune cells over time will help us predict if allergies will come back and how safe food allergy studies are. Study Duration and Procedures - The study will last 70 weeks and involve 21 clinic visits. - Clinic visits include, but are not limited to, a physical examination, blood tests, lung function test, skin prick test, and food challenges. Page 1 of 28 Participant ID: MOTIF Consent form V3.0 10 JUN 2019 IRB Use Only STANFORD UNIVERSITY Research Consent Form Approval Date: June 12, 2019 Expiration Date: June 12, 2020 Protocol Director: Kari Nadeau, MD PhD Protocol Title: T Cell Reagent Research for Monitoring T Cells in Food Allergy Phase 2 study using food Allergen Oral Immunotherapy for Shrimp or Cashew allergies Potential Study Risks and Benefits - Some risks and discomforts could include itchy rash, hives, nausea, vomiting, abdominal discomfort, diarrhea, cough, stuffy, runny nose, sneezing, facial swelling, wheezing and shortness of breath.
    [Show full text]
  • Single Center, Placebo Controlled Clinical Study in Desensitization Vs Tolerance Induction in Peanut Allergy Subjects
    Single Center, Placebo Controlled Clinical Study in Desensitization vs Tolerance Induction in Peanut Allergy Subjects Study Protocol NCT02103270 January 24, 2018 PROTOCOL NUMBER AADCRC-STAN-001 LONG TITLE: Single Center, Placebo Controlled Clinical Study in Desensitization vs. Tolerance Induction in Peanut Allergy Subjects SHORT TITLE: Tolerance vs. Desensitization in Peanut-Allergic Individuals VERSION NUMBER / VERSION DATE: 7 / January 24, 2018 IND# Amendment 14 Study Sponsor(s): The National Institute of Allergy and Infectious Diseases (NIAID) NIAID Funding Mechanism: AADCRC (PI, Galli) IND Sponsor: Kari C. Nadeau, MD, PhD Study Drug Manufacturer/Provider: Stanford CFRU (Clinical Food Research Unit, 4th Floor and cGMP facility, 1st Floor, Stanford Packard El Camino Hospital, 2500 Grant Rd, Mountain View, CA. PROTOCOL STATISTICIAN , PhD Stanford University Department of Medicine Palo Alto, CA 94304 Phone: Fax: E-mail: PROTOCOL CHAIR- CO-CHAIR Kari C. Nadeau, MD, PhD R. Sharon Chinthrajah, MD Stanford University (same) (same) Stanford, CA 94305 (same) Phone: 650-723-5227 (same) Fax: 650-498-5560 (same) E-mail: [email protected] [email protected] NIAID MEDICAL MONITOR- NIAID PROJECT MANAGER- REGULATORY OFFICER – , MD , RN, BSN Division of Allergy, Immunology, Division of Allergy, Immunology, and Division of Allergy, Immunology, and and Transplantation – NIAID/NIH Transplantation – NIAID/NIH Transplantation – NIAID/NIH Rockville, MD 20852 , USA Rockville, MD 20852, USA Rockville, MD 20852, USA Phone: Phone: Phone: E-mail: E-mail: Fax: E-mail: 1 Confidentiality Statement The information contained within this document is not to be disclosed in any way without the prior permission of the Protocol Chair, or the Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
    [Show full text]
  • 2015 Annual Meeting Program Book
    Supporting Postdocs, Promoting Discovery The only national meeting for administrators, postdocs, and faculty dedicated to supporting new researchers through innovative practices National Postdoctoral Association 13th Annual Meeting March 13 – 15, 2015 • Baltimore, Maryland Hosted by the University of Maryland, Baltimore Table of Contents Welcome ..............................................................................................................................................................................3 Agenda Agenda-at-a-Glance ......................................................................................................................Inside Front Cover Agenda, Friday, March 13 ..............................................................................................................................................7 Agenda, Saturday, March 14......................................................................................................................................12 Agenda, Sunday, March 15 ........................................................................................................................................21 Awards 2015 Distinguished Service Award Recipient .....................................................................................................25 2015 NPA Garnett-Powers & Associates, Inc. Mentor Award Recipient .....................................................27 Biographies Keynote Speaker ............................................................................................................................................................29
    [Show full text]
  • Primary Immunodeficiency Diseases Consortium Conference June 11, 2009 San Francisco, CA, USA
    Primary Immunodeficiency Diseases Consortium Conference June 11, 2009 San Francisco, CA, USA Final Report Overview The Primary Immunodeficiency Diseases Consortium Conference took place at the San Francisco Marriott in San Francisco, CA, on June 11, 2009, in conjunction with the Federation of Clinical Immunology Societies (FOCIS) Annual Meeting. This was the fifth Consortium on Primary Immunodeficiency Diseases. This year’s Consortium was co-organized by the Clinical Immunology Society (CIS) and the American Academy of Allergy, Asthma, & Immunology (AAAAI). This activity was intended to reach an international target audience consisting of fellows-in- training, junior faculty, as well as noted experts in the field. This symposium brought together experts in the field to discuss recent updates as well as material related to our understanding of the scientific processes affected in various primary immune deficiencies. Both by lecture and networking during the symposium, clinicians and researchers came away with an improved knowledge of primary immunodeficiencies. The material was delivered primarily in lecture format; however a poster session and scheduled breaks allowed networking, mentoring, and one-on-one time with the state-of-the art lecturers. The objectives for this conference were: to continue to advance understanding of the diagnosis, molecular defects, complications, and treatment of these complex diseases; to develop the careers of new scientists in this area of academic medicine; to enhance awareness of clinical immunology and its importance in scientific discoveries and clinical applications; and to stimulate future collaborations between investigators in different medical centers and countries, and between new investigators and experienced physician / scientists in the field. Organizers Six organizers were selected to review applications and attend the Consortium.
    [Show full text]
  • Download Spring/Summer 2013 Issue
    Friend on Campus The Allergy Buster Fords in Philly Nurturing Haverford’s Taking a daring approach to Making a home and Quaker spirit food allergies a life in the city The Magazine of Haverford College SPRING/SUMMER 2013 THE UNCONVENTIONAL COP ANDY SOLBERG ’78 is a D.C. police commander with a master’s in philosophy who thinks police work can be informed by the ethics of Aristotle and believes, “We arrest way too many people.” 6 33 Editor Contributing Writers DEPARTMENTS Eils Lotozo Sari Harrar Lini S. Kadaba Associate Editor Kathryn Masterson 2 View from Founders Rebecca Raber Anne E. Stein 4 Letters to the Editor Graphic Design Robert Strauss 6 Main Lines Tracey Diehl, Contributing Photographers Eye D Communications Thom Carroll 14 Faculty Profile Assistant Vice President for Dan Z. Johnson College Communications Greg Kahn 19 Ford Games Chris Mills ’82 Brad Larrison Nathan Michael 22 Mixed Media Vice President for Jim Roese Roads Taken and Not Taken Institutional Advancement 48 Michael Kiefer 49 Giving Back/Notes from the Alumni Association 55 Class News 65 Then and Now On the cover: Andy Solberg ’78, Photo by Greg Kahn Back cover photo: Courtesy of Haverford College Archives The Best of Both Worlds! Haverford magazine is now available in a digital edition. It preserves the look and page-flipping readability of the print edition while letting you search names and keywords, share pages of the magazine via email or social networks, as well as print to your personal computer. CHECK IT OUT AT haverford.edu/news/magazine Haverford magazine is printed on recycled paper that contains 30% post-consumer waste fiber.
    [Show full text]
  • NIEHS/EPA Children's Environmental Health and Disease Prevention Research Centers IMPACT REPORT Protecting Children's Health
    NIEHS/EPA Children's Environmental Health and Disease Prevention Research Centers IMPACT REPORT Protecting Children's Health Where They Live, Learn, and Play EPA/600/R-17/407 Children’s Health Matters The number 35% of children 8.4% diagnosed with 8.4% of leukemia children 1 in 42 8-year-old has in the U.S. boys have increased by have autism.3 asthma.2 35% over the past 40 years.1 Children in the U.S. are at high risk for chronic disease This may be a result of increasing exposures to environmental toxicants. Approximately 16,000 premature births per year in the U.S. are attributable to air pollution.4 60% of acute respiratory Children in infections in children 4 million worldwide U.S. households are related to may be exposed environmental to high levels of conditions.6 lead.5 Genetics were once thought to contribute 90% to autism, but are now thought to only contribute 41-56% in boys and 13-16% in girls. The role of Air pollution environmental contributes to factors in autism 600,000 deaths worldwide is greater than in children under previously thought.7 5 years old.8 2 Children are uniquely vulnerable to environmental risks Biology. Children’s brains, lungs, immune, and Behavior. Children’s behavior patterns make other systems are rapidly developing. Their natural them more susceptible to exposure. They crawl and defenses are less developed than adults; skin and play close to the ground, putting them in contact blood–brain barriers are more permeable, and with dirt and dust.
    [Show full text]
  • 313 Needs Assessment for an Infant and Toddler Food Allergy
    J ALLERGY CLIN IMMUNOL Abstracts AB99 VOLUME 147, NUMBER 2 Needs Assessment for an Infant and Toddler participants were unaware of the LEAP study and 51 (61%) did not know 313 Food Allergy Curriculum for Pediatric Residents about the addendum guidelines. CONCLUSIONS: This preliminary data demonstrates that there is a Marielle Young1, Ariel Frey-Vogel, MD1, Kristina Dzara, PhD, MMSc1, knowledge gap in pediatric residents and more education is necessary. This Michael Pistiner, MD MMSc2; 1MassGeneral Hospital for Children, is an ongoing project that will use didactic tools to ensure future 2MassGeneral Hospital for Children, Harva. implementation of the guidelines. RATIONALE: The prevalence of pediatric food allergies is increasing. Approximately 6% of children ages 0 to 2 years have a food allergy. A Quality Improvement Initiative to Improve Pediatric residents are frontline providers for children with food allergies, 315 Resident- Physician Practices Regarding Flu but little is known about their educational experiences and comfort Vaccine Administration in Individuals with Egg managing infant/toddler food allergies. Allergy METHODS: An anonymous online needs assessment survey was created 1 1 2 and distributed to pediatric residents in one residency program. The survey Aishwarya Navalpakam , Shweta Saini, MD , Chi- Lan Tran , Jenny Huang, MD1, Divya Seth2, Pavadee Poowuttikul, MD FAAAAI2; 1Chil- explored residents’ knowledge sources, experience and comfort diag- 2 nosing, treating and counseling patients regarding infant/toddler food dren’s Hospital of Michigan, Wayne State University. allergies. RATIONALE: Individuals with any severity of egg allergy, including RESULTS: Forty-nine pediatric residents (77%) responded. Prior to anaphylaxis, should receive the influenza vaccine annually per CDC residency, most residents (94%) did not have any formal training on infant/ guidelines.
    [Show full text]
  • Extreme Weather, Health, and Communities Interdisciplinary Engagement Strategies Extreme Weather and Society
    Extreme Weather and Society Sheila Lakshmi Steinberg William A. Sprigg Editors Extreme Weather, Health, and Communities Interdisciplinary Engagement Strategies Extreme Weather and Society Series editors William A. Sprigg, Tucson, AZ, USA Sheila Lakshmi Steinberg, Irvine, CA, USA Extreme Weather and Society examines people, place and extreme weather, from an emerging trans-disciplinary field of study. The series explores how abrupt and trending changes in weather alter physical environments and force community responses challenged by cultural practices/interpretations, politics, policy, respon- sibilities of education and communication, community health and safety, and environmental sustainability for future generations. The series highlights extreme weather alterations to different physical and social environments to better explore how people react and respond to extreme weather. The hallmark of this series is the innovative combined inclusion of social and physical science expertise. Extreme Weather and Society contains single and multi-authored books as well as edited volumes. Series Editors are currently accepting proposals, forms for which can be obtained from the publisher, Ron Doering ([email protected]). More information about this series at http://www.springer.com/series/15334 Sheila Lakshmi Steinberg • William A. Sprigg Editors Extreme Weather, Health, and Communities Interdisciplinary Engagement Strategies 123 Editors Sheila Lakshmi Steinberg William A. Sprigg School of Arts and Sciences Department of Atmospheric Sciences Brandman University-Chapman University The University of Arizona System Tucson, AZ Irvine, CA USA USA Extreme Weather and Society ISBN 978-3-319-30624-7 ISBN 978-3-319-30626-1 (eBook) DOI 10.1007/978-3-319-30626-1 Library of Congress Control Number: 2016934022 © Springer International Publishing Switzerland 2016 This work is subject to copyright.
    [Show full text]
  • YMAI12515 Proof 1..15
    All abstracts are strictly embargoed until the date of presentation at the 2017 Annual Meeting. J ALLERGY CLIN IMMUNOL Abstracts AB1 VOLUME 139, NUMBER 2 Staphylococcus Aureus Colonization Is Associated with of Club cell aberration to IPF was confirmed by marked pleomorphism and 1 Increased Atopy and Inhaled Steroid Use in Patients wide distribution of Cldn10-positive Club cells in IPF lungs. with Atopic Dermatitis and Asthma CONCLUSIONS: Oxidative stress induces aberrant fibrotic reactions in Atp8b1 mutant mice. This model can be a new format to unravel the role of Peter Uong, MD1, Douglas Curran-Everett, PhD1, and Donald Y. M. Club cells in the development of IPF. Leung, MD, PhD, FAAAAI2; 1National Jewish Health, Denver, CO, 2K926i, National Jewish Health, Denver, CO. Chronic Rhinitis Is A Strong Clinical Predictor for Early RATIONALE: Staphylococcus aureus (S. aureus) colonization has been 3 Hospital Readmission Of Chronic Obstructive Lung associated with severe atopic dermatitis (AD), and in experimental models, Disease Patients has been shown to increase IgE and corticosteroid insensitivity. We tested Umesh Singh, MD, PhD1, Victoria Wangia-Anderson, PhD2, Linda the hypothesis that S. aureus colonization may also contribute to increased 1 1,3 1 environmental allergen sensitization and severity of asthma. Levin, PhD , and Jonathan A. Bernstein, MD, FAAAAI ; University of Cincinnati College of Medicine, Cincinnati, OH, 2University of Cincin- METHODS: We reviewed the patient research database at National 3 Jewish Health and found 557 patients (less than or equal to 18 years of age) nati, College of Allied Health Sciences, Cincinnati, OH, Bernstein Al- SATURDAY with a concurrent diagnosis of AD and asthma who had been cultured for S lergy Group, Inc, Cincinnati, OH.
    [Show full text]
  • Thursday, February 21 / Friday, February 22
    Thursday, February 21 / Friday, February 22 Thursday, February 21 Friday, February 22 Military Allergy Program Fellows-in-Training Program 0001 27 th Annual Harold S. Nelson Allergy 1011 FIT Symposium Immunology Symposium 7:00 am to 1:30 pm 7:20 am to 5:00 pm Marriott Rivercenter, Third Floor, Grand Ballroom Salon G Convention Center, Concourse Level, Room 210AB Pre-registration and ticket required. No fee. Continental breakfast and Pre-registration and ticket required. No fee. Continental breakfast and box lunch included. box lunch included. Credit: No CME / No CE Credit: 8.00 CME / 9.60 CE Moderator: Silvia Huebner, MD Moderator: Thomas J. Backenson, MD 7:00 Networking Breakfast Begins 7:20 Registration and Breakfast 8:00 Introductory Remarks 7:50 Welcome and Overview Mary Beth Fasano, MD FAAAAI Thomas J. Backenson, MD Silvia Huebner, MD 8:00 Morning Address: Update in Mast Cell Biology and Mast Cell 8:05 Networking Organizations Disorders American Academy of Pediatrics Section on Allergy and Todd Wilson, DO Immunology 9:00 Break Anne-Marie A. Irani, MD FAAAAI 9:15 Fellow Research and Clinical Case Presentations Federation of Regional, State and Local Allergy, Asthma and 11:00 Vaccine Healthcare Center Update Immunology Societies Renata J.M. Engler, MD FAAAAI James M. Tracy, DO FAAAAI 11:30 Lunch and Bruton Lecture: VA Disability and Allergic Disease Joint Council of Allergy, Asthma & Immunology Chester R. Zeiss, MD FAAAAI James L. Sublett, MD FAAAAI 1:00 Fellow Case Reports New Allergist/Immunologist Assembly 2:45 Break David W. Hauswirth, MD FAAAAI 3:00 Military Aeroallergen Extract Laboratory Updates World Allergy Organization Susan E.
    [Show full text]
  • Abstracts of the CEHN Conference: the Contributions of Epigenetics In
    CEHN Research Conference San Francisco, CA May 30–June 1, 2012 The Contribution of Epigenetics in Pediatric Environmental Health 2012 Children’s Environmental Health Network CEHN Research The Contribution of Conference Epigenetics in Pediatric San Francisco, CA Environmental Health May 30–June 1, 2012 TABLE of CONTENTS Keynote Presentations 10 Mechanisms 16 Placental Epigenetics and Infant 4 Developmental Stressors and Cynthia Bearer, moderator Neurobehavior Epigenetics Carmen J. Marsit, Cailey Bromer, James F. Dana Dolinoy 10 Epigenetic Regulation after Padbury, Barry M. Lester 4 Embryo Vulnerability in An Always Environmental Intervention 17 Methylation Levels at Imprinting Changing World: Epigenetics and Stephanie Lovinsky-Desir, R. Ridder, D. Torone, Control Regions Are Not Altered with H. Jiang, S. Narula, M. Kattan, E. DiMango, Fertility Treatments Beyond R.L. Miller David Epel R.C. Rancourt, H.R. Harris, K.B. Michels 11 Epigenetic Changes in IFN-gamma 5 Developmental Origins of Health and 17 A Genomic & Epigenomic Integration and FoxP3 due to SHS Approach on Obesity Disease (DOHaD)—New Insights and Arunima Kohli, Marco Garcia, Olivier Humblet, Opportunities Shaoyong Su, Haidong Zhu, Harold Snieder, John Balmes, Katharine Hammond, Ira Tager, Yanbin Dong, Frank Treiber, Bernard Gutin, Mark A. Hanson Kari Nadeau Gregory Harshfield, Xiaoling Wang 5 Epigenetics: A Biological Database for 11 The Role of PBRM1 in Malignant “Personalized Medicine” Rhabdoid Tumor Development 18 Critical Windows of Early Robert H. Lane Darmood Wei, Yasumichi Kuwahara, Bernard E. Weissman Exposure & Sensitivity II 6 Effects of Prenatal Environmental Richard Finnell, moderator Exposures on Child Health and 12 Choline Prevents Ethanol Inhibition of Development Neurite Outgrowth 18 Epigenetic Marks of Impaired Glucose Frederica P.
    [Show full text]